Zhou, Jian
Kou, Minghao
Tang, Rui
Wang, Xuan
Li, Xiang
Heianza, Yoriko
Manson, JoAnn E.
Qi, Lu
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (HL071981)
National Heart, Lung, and Blood Institute (HL034594)
National Heart, Lung, and Blood Institute (HL126024)
National Institute of Diabetes and Digestive and Kidney Diseases (DK115679)
National Institute of Diabetes and Digestive and Kidney Diseases (DK091718)
National Institute of Diabetes and Digestive and Kidney Diseases (DK100383)
National Institute of Diabetes and Digestive and Kidney Diseases (DK078616)
National Institute of General Medical Sciences (2P20GM109036-06A1)
National Institute of General Medical Sciences (Sub-Project ID 7233)
Article History
Received: 31 January 2024
Accepted: 23 December 2024
First Online: 22 January 2025
Declarations:
:
: The UK Biobank study was approved by the National Health and Social Care Information Management Board and the North West Multicentre Research Ethics Committee (11/NW/0382), and the Institutional Review Board of Tulane University (2018–1872).
: The funding sources and sponsor had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
: LQ affirms that the manuscript is an honest, accurate, and transparent account of the study being reported; that no important aspects of the study have been omitted, and that any discrepancies from the study as planned have been explained.
: The authors declare no conflicts of interest.